Macquarie Group
SGNT

Macquarie Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Macquarie Group’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-48
Closed -$1K – 1663
2014
Q3 		$1K Buy
+48
New +$1.3K ﹤0.01% 1553

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Macquarie Group's SGNT Position: Q4 2014 in Review

Macquarie Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q4 2014, closing a stake of 48 shares — an estimated $1K sold.

Macquarie Group first reported a position in SGNT in Q3 2014 and held it in 1 quarter. The position peaked at $1K in Q3 2014. 131 funds tracked by Wall St. Rank hold SGNT as of Q4 2014.

  • Macquarie Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Macquarie Group sold 48 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $1K.
  • Macquarie Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 1 quarter.
  • Macquarie Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1K in Q3 2014.
  • 131 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on Macquarie Group's 13F filing for Q4 2014, filed 17 Feb 2015.